Kaico

Manufacturer of portfolio of proteins and other biological cytokines and enzymes

placeFukuoka, Fukuoka, Japan calendar_todayFounded 2018 groups10 employees language kaicoltd.jp

Innovation

4 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 45 times.

YearFilings
20201
20221
20233
20241
20252

Investor mix

10 investors on record; lead investors include FFG Venture Business Partners, Tokyo Century, ITOCHU Technology Ventures, Mizuho Capital.

Investor typeCountShare
Venture capital330%
Private equity220%
Accelerator & incubator110%
Other / undisclosed440%
Coming soon